News & Opinion

Covering the life sciences inside and out

Most Recent

Nogo for axon regeneration

By | May 31, 2002

Nogo receptor antagonists promote axonal regeneration after spinal cord trauma and may improve functional recovery.

0 Comments

Wily wasps ferment ant civil war

By | May 31, 2002

Secretions from a parasitoid wasp induce ants to attack their kin, leaving the wasp a free run at the larvae in the nest.

0 Comments

Inventory of secreted proteins

By | May 30, 2002

Genomic sequence analysis identifies pathogenicity proteins secreted into host cells by a plant pathogen.

0 Comments

Max Perutz Awards 2002

By | May 30, 2002

Annual essay prizes go to those scientists who can explain the nub of their work.

0 Comments

Silvereye birds explain evolution

By | May 30, 2002

Single silvereye colonization events are rarely accompanied by severe founder effects, suggesting new species arise gradually.

0 Comments

2

By | May 29, 2002

channel function.

0 Comments

Cow clones

By | May 29, 2002

X-chromosome inactivation, the largest epigenetic event known, involves random silencing of one of the two X chromosomes in the cells of female mammals. In an Advanced Early Publication in Nature Genetics, Fei Xue and colleagues report defects in X inactivation in cells from cloned bovine embryos (NatGenet 2002, DOI:10.1038/ng900).Xue etal. looked at the allele-specific expression of the X-linked monoamine oxidase type A (MAOA) gene and at the expression of Xist and other X-linked genes in clone

0 Comments

Smallpox repays the complement

By | May 29, 2002

The variola virus overcomes human viral clearance by inactivation of complement components C3b and C4b.

0 Comments

Comparing Xanthomonas

May 28, 2002

Comparison of the sequence of two phytopathogen genomes reveals insights into the molecular basis for host specificity and pathogenicity.

0 Comments

Genes contributing to heart attack identified

By | May 28, 2002

Loci on chromosomes two, three and 20 are implicated in susceptibility to myocardial infarction.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS